Market Place
Sourcing Support
Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results
03 Mar 2025 //
GLOBENEWSWIRE
Biodesix to Present at TD Cowen Health Care Conference
26 Feb 2025 //
GLOBENEWSWIRE
Biodesix to Report Q4 & Full Year 2024 Financial Results
18 Feb 2025 //
GLOBENEWSWIRE
Biodesix Announces Preliminary Q4 & Full-Year 2024 Results
10 Jan 2025 //
GLOBENEWSWIRE
Biodesix Releases New Nodify CDT Validation Study
07 Jan 2025 //
GLOBENEWSWIRE
Biodesix Announces Third Quarter 2024 Results and Highlights
01 Nov 2024 //
GLOBENEWSWIRE
Biodesix to Participate in Three Investor Conferences in November
29 Oct 2024 //
GLOBENEWSWIRE
Biodesix To Report Q3 2024 Financial Results On Nov. 1
18 Oct 2024 //
BUSINESSWIRE
Biodesix Announces Data Presentation At CHEST 2024 Annual Meeting
07 Oct 2024 //
BUSINESSWIRE
Biodesix to Present at Two Investor Conferences in September
05 Sep 2024 //
BUSINESSWIRE
Biodesix Announces Second Quarter 2024 Results and Highlights
07 Aug 2024 //
BUSINESSWIRE
Biodesix to Present at Canaccord Genuity’s 44th Annual Growth Conference
06 Aug 2024 //
BUSINESSWIRE
Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024
24 Jul 2024 //
BUSINESSWIRE
Biodesix Named To Inc. Magazine’s 2024 “Best Workplaces”
18 Jun 2024 //
BUSINESSWIRE
Biodesix to Participate in Two Investor Conferences in June
28 May 2024 //
BUSINESSWIRE
Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting
21 May 2024 //
BUSINESSWIRE
Biodesix: Q1 2024 Results, Lung Diagnostic Testing Growth
08 May 2024 //
BUSINESSWIRE
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
07 May 2024 //
BUSINESSWIRE
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
24 Apr 2024 //
BUSINESSWIRE
Biodesix to Present Liquid Biopsy Data at AACR 2024
10 Apr 2024 //
BUSINESSWIRE
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering
05 Apr 2024 //
BUSINESSWIRE
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results
01 Mar 2024 //
BUSINESSWIRE
Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference
01 Aug 2023 //
BUSINESSWIRE
Biodesix Announces Four Presentations of Health Economic Data
25 May 2023 //
BUSINESSWIRE
Biodesix Announces Fourth Quarter & Fiscal Year End 2022 Results and Highlights
06 Mar 2023 //
BUSINESSWIRE
Biodesix to Report Q4 and Full Year 2022 Financial Results on March 6, 2023
21 Feb 2023 //
BUSINESSWIRE
Biodesix Announces Preliminary Revenue for Third Quarter 2022
11 Oct 2022 //
BUSINESSWIRE
Biodesix Announces Second Quarter 2022 Results and Highlights
04 Aug 2022 //
BUSINESSWIRE
Philips incorporates Biodesix blood-based proteomic nodule RMS testing
30 Jun 2022 //
GLOBENEWSWIRE
Biodesix Announces New Clinical Utility Evidence for the Nodify XL2 at ATS 2022
12 May 2022 //
BUSINESSWIRE
Biodesix Announces First Quarter 2022 Results and Highlights
11 May 2022 //
BUSINESSWIRE
Biodesix Strengthens Financial Position
11 Apr 2022 //
BUSINESSWIRE
